![Eric Sarin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Eric L.
Sarin is the founder of Nyra Medical, Inc. He held the title of Chief Medical Officer at the company, but is no longer active in that role.
Postes actifs de Eric Sarin
Sociétés | Poste | Début |
---|---|---|
Nyra Medical, Inc.
![]() Nyra Medical, Inc. Medical SpecialtiesHealth Technology The American company is focused on developing the Carlen technology, a transcatheter technology for the treatment of mitral regurgitation. The technology preserves the physiological valve geometry while restoring its function, eliminates the risk of stenosis, and offers the benefit of preserving a full range of transcatheter and surgical treatments as future options. Nyra Medical is also developing a novel transcatheter mitral and tricuspid valve repair technology called the Cardiac Leaflet Enhancer (Carlen), which enables repair of leaky heart valves without the need for open heart surgery. Lori B. Chmura has been the CEO of the company since 2023. | Fondateur | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
Nyra Medical, Inc.
![]() Nyra Medical, Inc. Medical SpecialtiesHealth Technology The American company is focused on developing the Carlen technology, a transcatheter technology for the treatment of mitral regurgitation. The technology preserves the physiological valve geometry while restoring its function, eliminates the risk of stenosis, and offers the benefit of preserving a full range of transcatheter and surgical treatments as future options. Nyra Medical is also developing a novel transcatheter mitral and tricuspid valve repair technology called the Cardiac Leaflet Enhancer (Carlen), which enables repair of leaky heart valves without the need for open heart surgery. Lori B. Chmura has been the CEO of the company since 2023. | Health Technology |